- Home
- OCC vs ATNM Comparison
OCC vs ATNM Comparison
Compare OCC & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- ATNM
- Stock Information
- Founded
- OCC 1983
- ATNM 2000
- Country
- OCC United States
- ATNM United States
- Employees
- OCC N/A
- ATNM N/A
- Industry
- OCC Telecommunications Equipment
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- OCC Industrials
- ATNM Health Care
- Exchange
- OCC Nasdaq
- ATNM Nasdaq
- Market Cap
- OCC 42.9M
- ATNM 46.5M
- IPO Year
- OCC 1996
- ATNM N/A
- Fundamental
- Price
- OCC $2.81
- ATNM $1.50
- Analyst Decision
- OCC
- ATNM Strong Buy
- Analyst Count
- OCC 0
- ATNM 4
- Target Price
- OCC N/A
- ATNM $8.75
- AVG Volume (30 Days)
- OCC 24.6K
- ATNM 1.3M
- Earning Date
- OCC 03-10-2025
- ATNM 04-25-2025
- Dividend Yield
- OCC N/A
- ATNM N/A
- EPS Growth
- OCC N/A
- ATNM N/A
- EPS
- OCC N/A
- ATNM N/A
- Revenue
- OCC $67,561,951.00
- ATNM N/A
- Revenue This Year
- OCC N/A
- ATNM N/A
- Revenue Next Year
- OCC N/A
- ATNM N/A
- P/E Ratio
- OCC N/A
- ATNM N/A
- Revenue Growth
- OCC N/A
- ATNM N/A
- 52 Week Low
- OCC $2.02
- ATNM $1.03
- 52 Week High
- OCC $7.00
- ATNM $10.24
- Technical
- Relative Strength Index (RSI)
- OCC 32.38
- ATNM 54.24
- Support Level
- OCC $2.57
- ATNM $1.66
- Resistance Level
- OCC $3.67
- ATNM $2.41
- Average True Range (ATR)
- OCC 0.27
- ATNM 0.23
- MACD
- OCC -0.02
- ATNM 0.03
- Stochastic Oscillator
- OCC 21.82
- ATNM 27.20
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.